NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a key milestone in their partnership to develop new analysis tools to accelerate research on NanoString’s nCounter® Analysis System. After successful completion of an Early Access Program announced in May, the parties are expanding access to new analysis capabilities to all nCounter users. The new analysis functionality is built into ROSALIND®, OnRamp’s cloud-based analysis platform that facilitates data visualization, exploration and collaboration. NanoString will support ROSALIND as a preferred analysis solution for nCounter data and make it broadly available to users of the nCounter Analysis System.
Search
Recent Posts
See AllIt's a nightmare the very sick can find themselves in: Communicating their health history from one doctor to the next to get the critical care they need. It's been an extra burden during this already
As a nation we have fallen short on the promise of the American Dream, that every generation should enjoy a higher quality of life than the generation before it. US adolescents and young adults are in